Latest Artemisinin Stories
2014 marks the first time The Economist's innovation initiative has come to Asia in its 13-year history HONG KONG, Sept.
First shipment marks a critical step in improving access to treatment worldwide PARIS and SOUTH SAN FRANCISCO, Calif., Aug.
Preventative treatment with a monthly dose of a newer antimalarial drug can reduce the risk of malarial infection among young children.
Malaria No More, APLMA and the ADB join forces to mobilize resources and rally regional leadership in endemic Asia SINGAPORE, August 1st, 2014 /PRNewswire-USNewswire/ -- In an effort
Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programs.
‘Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine’ concludes a systematic review published by the Cochrane Infectious Disease Group, hosted by LSTM.
Despite gains, recent financial shortfalls and delays in the delivery of commodities have slowed progress, demonstrating the fragility of past success, according to findings of the World Health
Antimalarial drug resistance has hampered malaria control programs for almost 60 years.
The first dynamic regulatory system that prevents the build-up of toxic metabolites in engineered microbes has been reported by a team of researchers with the U.S. Department of Energy (DOE)’s Joint BioEnergy Institute (JBEI).
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.